Does vaccination reduce long COVID risk? Research suggests illness severity and vaccination status influence the chance of patients seeking medical care in the six months post-infection.
Queries over long COVID prevalence in Australia An international review estimates that 'at least' one in 10 people with COVID-19 will develop lasting symptoms, but that may overstate the risk.
‘A constellation of symptoms’: Long COVID in focus The first public hearing into long COVID has taken place as clinicians attempt to work out the scale of the problem, and one GP reports a rising demand for treatment.
What are the long-term health risks following COVID-19? Sequelae may include persistent pulmonary damage, post-viral fatigue and chronic cardiac complications.